follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Actavis, Valeant announce marketing deal

By

Back to Top Comments Email Print

Latest News

    advertisement

    Actavis Inc., in Parsippany, announced today it will exclusively market a generic version Zovirax for Valeant Pharmaceuticals International Inc.

    In addition, Valeant has granted Actavis the exclusive right to co-promote Zovirax cream to obstetricians and gynecologists in the United States, and Actavis has granted Valeant the exclusive right to co-promote its Cordran product in the United States. Terms were not disclosed.

    Share This Story On:

    Write to the Editorial Department at editorial@njbiz.com

    advertisement

    Comments


    Be the first to comment.



    Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

    Post Comment
         View Comment Policy

    Advanced search
    Sponsored by
    advertisement
      
      
    advertisement
      
      
    advertisement
    Back to Top